SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,933.59 -539.35
( -0.70%)

Global Indices

Nasdaq

53,487.87 -110.53
(-0.21%)

Dow Jones

7,697.38 -0.90
(-0.01%)

Hang Seng

66,058.92 -203.24
(-0.31%)

Nikkei 225

10,795.58 -82.54
(-0.76%)

Forex

USD-INR

95.31 -0.39
(-0.41%)

EUR-INR

111.19 -0.48
(-0.43%)

GBP-INR

129.97 -0.53
(-0.40%)

JPY-INR

0.60 0.00
(-0.54%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Krishna Institute of Medical Sciences Ltd

Industry : Healthcare

BSE Code

ISIN Demat

Book Value()

543308

INE967H01025

93.5396923

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KIMS

116.14

31756.69

EPS(TTM)

Face Value()

Div & Yield %

6.51

Back

Gland Pharma consolidated net profit rises 47.09% in the June 2026 quarter

Aug 10,2026

Net profit of Gland Pharma rose 47.09% to Rs 316.96 crore in the quarter ended June 2026 as against Rs 215.48 crore during the previous quarter ended June 2025. Sales rose 19.57% to Rs 1800.27 crore in the quarter ended June 2026 as against Rs 1505.62 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1800.27	1505.62	20
OPM %	27.18	24.43	-
PBDT	546.23	413.79	32
PBT	434.98	312.74	39
NP	316.96	215.48	47

76,933.59 -539.35 ( -0.70%)

53,487.87 -110.53 (-0.21%)

7,697.38 -0.90 (-0.01%)

66,058.92 -203.24 (-0.31%)

10,795.58 -82.54 (-0.76%)

95.31 -0.39 (-0.41%)

111.19 -0.48 (-0.43%)

129.97 -0.53 (-0.40%)

0.60 0.00 (-0.54%)